JUSTIN JELINSKI: Open Payments
NPI 1710237748 · LIBERTYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,607 in 194 payments from 15 companies in 2025. Trend: 2023 $1,527 · 2024 $5,673 · 2025 $2,607
Food & beverage: $2,607
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 32 | $550 |
| Janssen Pharmaceuticals, Inc | 37 | $510 |
| ABBVIE INC. | 30 | $280 |
| Lundbeck LLC | 14 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $196 |
| Vanda Pharmaceuticals Inc. | 17 | $178 |
| Axsome Therapeutics, Inc. | 14 | $159 |
| Corium, LLC | 12 | $120 |
| Tris Pharma Inc | 5 | $101 |
| Teva Pharmaceuticals USA, Inc. | 5 | $85 |
Products named: REXULTI, SPRAVATO, VRAYLAR, CAPLYTA, FANAPT, Auvelity, INVEGA SUSTENNA, Azstarys.
Industry payments across IL — which companies pay providers there.
